Oct 25 Indian drugmaker Wockhardt Ltd
reported a 69 percent fall in quarterly profit, hit by curbs on
shipping medicines to the United States and Britain from one of
its plants after their health regulators identified quality
Wockhardt posted a net profit of 1.4 billion rupees ($23
million) for the three months ended Sept. 30, compared with 4.5
billion rupees a year ago. Revenues fell 11 percent to 12
billion rupees, the company said in a statement on Friday.
The average estimate for the company's net profit was 2.4
billion rupees, according to a Reuters poll of two brokerages.
Wockhardt has previously said the U.S. ban on the Waluj
factory in western India, reported in May, could cost the
company about $100 million in sales a year.
The United States and Europe accounted for three-quarters of
the company's revenues in the last fiscal year that ended in